Agenda - ACT EU multi-stakeholder platform annual meeting
Submitted by Anonymous (not verified) on 21 October 2024 - 11:15
Agenda - ACT EU multi-stakeholder platform annual meeting
Quality Drafting Group
Submitted by Anonymous (not verified) on 21 October 2024 - 8:24
Quality Drafting Group
Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)
Submitted by Anonymous (not verified) on 21 October 2024 - 8:22
Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)
Veterinary medicines European public assessment report (EPAR): Purevax RC, vaccine against feline viral rhinotracheitis and feline calicivirosis, Status: Authorised
Submitted by Anonymous (not verified) on 18 October 2024 - 15:51
Veterinary medicines European public assessment report (EPAR): Purevax RC, vaccine against feline viral rhinotracheitis and feline calicivirosis, Status: Authorised
Questions and answers about the clinical study data proof-of-concept pilot for industry
Submitted by Anonymous (not verified) on 18 October 2024 - 15:48
Questions and answers about the clinical study data proof-of-concept pilot for industry
Guideline on quality data requirements for applications for biological veterinary medicinal products intended for limited markets
Submitted by Anonymous (not verified) on 18 October 2024 - 15:10
Guideline on quality data requirements for applications for biological veterinary medicinal products intended for limited markets
Quality data requirements for applications for biological veterinary medicinal products intended for limited markets - Scientific guideline
Submitted by Anonymous (not verified) on 18 October 2024 - 15:10
Quality data requirements for applications for biological veterinary medicinal products intended for limited markets - Scientific guideline
Concept paper for the revision of the guideline on anticoccidials used for the therapy of coccidiosis in chickens, turkeys and geese
Submitted by Anonymous (not verified) on 18 October 2024 - 14:50
Concept paper for the revision of the guideline on anticoccidials used for the therapy of coccidiosis in chickens, turkeys and geese
Efficacy and target animal safety data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6 - Scientific guideline
Submitted by Anonymous (not verified) on 18 October 2024 - 14:30
Efficacy and target animal safety data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6 - Scientific guideline
Conversations on Cancer: Transforming patient lives by therapeutic and regulatory innovations, European Medicines Agency, Amsterdam, the Netherlands, from 1 February 2024, 15:30 (CET) to 1 February 2024, 17:00 (CET)
Submitted by Anonymous (not verified) on 18 October 2024 - 14:13
Conversations on Cancer: Transforming patient lives by therapeutic and regulatory innovations, European Medicines Agency, Amsterdam, the Netherlands, from 1 February 2024, 15:30 (CET) to 1 February 2024, 17:00 (CET)